Bionomics BNOX Stock
Bionomics Price Chart
Bionomics BNOX Financial and Trading Overview
| Bionomics stock price | 1 USD |
| Previous Close | 2.4 USD |
| Open | 2.5 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 900 |
| Day's Range | 2.4 - 2.5 USD |
| 52 Week Range | 1.8 - 10.9 USD |
| Volume | 1.47K USD |
| Avg. Volume | 35.2K USD |
| Market Cap | 21.96M USD |
| Beta (5Y Monthly) | 2.256704 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
BNOX Valuation Measures
| Enterprise Value | -10215090 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3162161 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6486044 |
| Price/Book (mrq) | 0.42274302 |
| Enterprise Value/Revenue | -1.697 |
| Enterprise Value/EBITDA | 0.513 |
Trading Information
Bionomics Stock Price History
| Beta (5Y Monthly) | 2.256704 |
| 52-Week Change | -62.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.9 USD |
| 52 Week Low | 1.8 USD |
| 50-Day Moving Average | 2.33 USD |
| 200-Day Moving Average | 4.88 USD |
BNOX Share Statistics
| Avg. Volume (3 month) | 35.2K USD |
| Avg. Daily Volume (10-Days) | 3.59K USD |
| Shares Outstanding | 8.16M |
| Float | 5.44M |
| Short Ratio | 0.5 |
| % Held by Insiders | 0% |
| % Held by Institutions | 7.76% |
| Shares Short | 6.33K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.080% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -346.16% |
| Gross Margin | -229.036% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.97% |
| Return on Equity (ttm) | -46.13% |
Income Statement
| Revenue (ttm) | 6.02M USD |
| Revenue Per Share (ttm) | 0.72 USD |
| Quarterly Revenue Growth (yoy) | -21.60% |
| Gross Profit (ttm) | -9943677 USD |
| EBITDA | -19929630 USD |
| Net Income Avi to Common (ttm) | -24913854 USD |
| Diluted EPS (ttm) | -2.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 30.7M USD |
| Total Cash Per Share (mrq) | 3.76 USD |
| Total Debt (mrq) | 614.55K USD |
| Total Debt/Equity (mrq) | 1.29 USD |
| Current Ratio (mrq) | 9.053 |
| Book Value Per Share (mrq) | 5.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17925264 USD |
| Levered Free Cash Flow (ttm) | -6967175 USD |
Profile of Bionomics
| Country | United States |
| State | SA |
| City | Eastwood |
| Address | 200 Greenhill Road |
| ZIP | 5063 |
| Phone | 61 8 8150 7400 |
| Website | https://www.bionomics.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
Q&A For Bionomics Stock
What is a current BNOX stock price?
Bionomics BNOX stock price today per share is 1 USD.
How to purchase Bionomics stock?
You can buy BNOX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bionomics?
The stock symbol or ticker of Bionomics is BNOX.
Which industry does the Bionomics company belong to?
The Bionomics industry is Biotechnology.
How many shares does Bionomics have in circulation?
The max supply of Bionomics shares is 10.69M.
What is Bionomics Price to Earnings Ratio (PE Ratio)?
Bionomics PE Ratio is now.
What was Bionomics earnings per share over the trailing 12 months (TTM)?
Bionomics EPS is -2.34 USD over the trailing 12 months.
Which sector does the Bionomics company belong to?
The Bionomics sector is Healthcare.
Bionomics BNOX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}